Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Emmaus Life Sciences Inc. (EMMA)

1.47   -0.07 (-4.55%) 08-13 15:51
Open: 1.46 Pre. Close: 1.54
High: 1.47 Low: 1.45
Volume: 4,617 Market Cap: 71M
Emmaus Life Sciences, Inc. engages in the discovery, development, and commercialization of treatments and therapies primarily for rare and orphan diseases in the United States and internationally. It provides Endari, which is L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older; NutreStore L-glutamine powder; and AminoPure, a nutritional supplement. The company also develops therapeutic products based on cell sheet technology for the treatment of corneal diseases. In addition, it focuses on developing pharmaceutical-grade L-glutamine oral powder for diverticulosis. The company was formerly known as Emmaus Holdings, Inc. and changed its name to Emmaus Life Sciences, Inc. in September 2011. Emmaus Life Sciences, Inc. was founded in 2000 and is headquartered in Torrance, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.472 - 1.481 1.481 - 1.487
Low: 1.428 - 1.44 1.44 - 1.448
Close: 1.455 - 1.472 1.472 - 1.484

Technical analysis

as of: 2020-08-13 4:33:40 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 2.18     One year: 2.52
Support: Support1: 1.40    Support2: 1.16
Resistance: Resistance1: 1.87    Resistance2: 2.16
Pivot: 1.74
Moving Average: MA(5): 1.55     MA(20): 1.81
MA(100): 1.59     MA(250): 1.98
MACD: MACD(12,26): -0.08     Signal(9): -0.03
Stochastic oscillator: %K(14,3): 16.81     %D(3): 16.22
RSI: RSI(14): 37.48
52-week: High: 4.50  Low: 0.85  Change(%): -55.2
Average Vol(K): 3-Month: 2514  10-Days: 1289

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
EMMA has closed above bottom band by 16.9%. Bollinger Bands are 52.2% wider than normal. The large width of the bands suggest high volatility as compared to EMMA's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue.

Headline News

Wed, 05 Aug 2020
Emmaus Life Sciences Reports Additional Positive Preliminary Results in Diverticulosis Pilot Trial - GlobeNewswire

Fri, 31 Jul 2020
Emmaus Life Sciences Provides Additional Operational and OTC Markets Updates - GlobeNewswire

Wed, 29 Jul 2020
Emmaus Life Sciences Receives Scientific Advice From the EMA Regarding Xyndari™ - GlobeNewswire

Mon, 27 Jul 2020
24/7 Market News- U.S. government plows more into its existing Moderna contract - Reported Times

Thu, 23 Jul 2020
Emmaus Life Sciences Accelerates Middle East and North Africa (MENA) Growth Strategy with Opening of its Dubai Office - GlobeNewswire

Mon, 20 Jul 2020
How is Emmaus Life Sciences Inc (EMMA) Stock's Recent Performance Affecting Investor's Feelings? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Other OTC
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 48
Shares Float (M) 29
% Held by Insiders 21.59
% Held by Institutions 0.48
Shares Short (K) 41
Shares Short P. Month (K) 34

Stock Financials

EPS -2.089
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) -0.370
Profit Margin
Operating Margin -15.20
Return on Assets (ttm) -3.2
Return on Equity (ttm)
Qtrly Rev. Growth 24.6
Gross Profit (p.s.) 0.295
Sales Per Share 0.497
EBITDA (p.s.) -0.074
Qtrly Earnings Growth
Operating Cash Flow (M) -6
Levered Free Cash Flow (M) 10

Stock Valuations

PE Ratio -0.70
PEG Ratio
Price to Book value -3.97
Price to Sales 2.96
Price to Cash Flow -11.89

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.